28/02/2024 - 13:53

Perth biotech’s stroke drug in nationwide trial

28/02/2024 - 13:53

Bookmark

Upgrade your subscription to use this feature.

Perth biotech company Argenica Therapeutics’ drug, which is designed to reduce brain tissue death following a stroke, will be administrated at two local hospitals in a nationwide trial.

Subscribe today for award-winning, unbiased and trusted journalism

Subscription Options